Homrich & Berg’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Homrich & Berg's EW Position: Q3 2021 in Review
Homrich & Berg reduced its Edwards Lifesciences (EW) stake by 0.21% in Q3 2021, selling an estimated $2.28K and leaving 9,325 shares worth $1.06M. The position accounts for 0.02% of the portfolio, ranked #214.
Homrich & Berg first reported a position in EW in Q1 2015 and has held it in 17 quarters since. The position peaked at $1.32M in Q3 2016. 1,227 funds tracked by Wall St. Rank hold EW as of Q3 2021.
- Homrich & Berg held 9,325 shares of Edwards Lifesciences worth $1.06M as of Q3 2021.
- Homrich & Berg sold 20 Edwards Lifesciences shares in Q3 2021, an estimated $2.28K.
- Edwards Lifesciences made up 0.02% of Homrich & Berg's portfolio in Q3 2021, its #214 holding.
- Homrich & Berg first reported a position in Edwards Lifesciences in Q1 2015 and has held it in 17 quarters since.
- Homrich & Berg's Edwards Lifesciences position peaked at $1.32M in Q3 2016.
- 1,227 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2021.
Based on Homrich & Berg's 13F filing for Q3 2021, filed 8 Dec 2021.